BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36135078)

  • 1. A Study of Peripheral Blood Parameters to Predict Response to Induction Chemotherapy and Overall Survival in Advanced Laryngeal Squamous Cell Carcinoma.
    Xu J; Yang Y; Zhong Q; Hou L; Ma H; Zhang Y; Feng L; He S; Lian M; Fang J; Wang R
    Curr Oncol; 2022 Sep; 29(9):6472-6484. PubMed ID: 36135078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma.
    Cui J; Wang L; Zhong W; Chen Z; Tan X; Yang H; Chen J; Liu G
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and Prognostic Value of Fibrinogen, Fibrinogen Degradation Products, and Lymphocyte/Monocyte Ratio in Patients With Laryngeal Squamous Cell Carcinoma.
    Han Y; Ren Z; Liu Y; Liu Y
    Ear Nose Throat J; 2024 May; 103(5):NP278-NP288. PubMed ID: 34672822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of nomogram models for predicting postoperative prognosis of early-stage laryngeal squamous cell carcinoma.
    Juan X; Jiali H; Ziqi L; Liqing Z; Han Z
    Curr Probl Cancer; 2024 Apr; 49():101079. PubMed ID: 38492281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development and validation of nomogram for predicting prognosis of patients with laryngeal squamous cell carcinoma after surgery].
    Xu J; Zhang L; Dong W; Chen X; Zhou H; Yin M
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 36(12):902-909. PubMed ID: 36543396
    [No Abstract]   [Full Text] [Related]  

  • 6. The prognostic role of coagulation markers in the progression and metastasis of laryngeal squamous cell carcinoma.
    Huang Q; Chen J; Huang Y; Xiong Y; Zhou J; Zhang Y; Lu M; Hu W; Zheng F; Zheng C
    BMC Cancer; 2023 Sep; 23(1):901. PubMed ID: 37749514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
    Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failed larynx preservation and survival in patients with advanced larynx cancer.
    Nocon CC; Yesensky J; Ajmani GS; Bhayani MK
    Am J Otolaryngol; 2019; 40(4):542-546. PubMed ID: 31036417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Larynx Preservation in Patients With Locally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx Treated With Induction Chemotherapy vs. Concurrent Chemoradiation Alone.
    Nehlsen AD; Lehrer EJ; Dickstein DR; Posner MR; Misiukiewicz K; Liu J; Gupta V; Bakst RL; Sharma S
    Cureus; 2021 Jul; 13(7):e16310. PubMed ID: 34405069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
    Fong PY; Tan SH; Lim DWT; Tan EH; Ng QS; Sommat K; Tan DSW; Ang MK
    PLoS One; 2019; 14(11):e0224665. PubMed ID: 31747406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
    Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
    Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma.
    Li R; Ye L; Zhu Y; Ding H; Wang S; Ying H; Wu C; Zhou L; Wang X; Tian S
    Head Neck; 2022 Sep; 44(9):2018-2029. PubMed ID: 35915867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
    Hitt R; Iglesias L; López-Pousa A; Berrocal-Jaime A; Grau JJ; García-Girón C; Martínez-Trufero J; Guix M; Lambea-Sorrosal J; Del Barco-Morillo E; León-Vintró X; Cunquero-Tomas AJ; Baste N; Ocaña A; Cruz-Hernández JJ;
    Clin Transl Oncol; 2021 Apr; 23(4):764-772. PubMed ID: 32797376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion.
    Worden FP; Moyer J; Lee JS; Taylor JM; Urba SG; Eisbruch A; Teknos TN; Chepeha DB; Prince ME; Hogikyan N; Lassig AA; Emerick K; Mukherji S; Hadjiski L; Tsien CI; Miller TH; Wallace NE; Mason HL; Bradford CR; Wolf GT
    Laryngoscope; 2009 Aug; 119(8):1510-7. PubMed ID: 19504552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Genomic-Clinicopathologic Nomogram Predicts Survival for Patients with Laryngeal Squamous Cell Carcinoma.
    Cui J; Wen Q; Tan X; Chen Z; Liu G
    Dis Markers; 2019; 2019():5980567. PubMed ID: 31827637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of Epigenetic Signature Predict Survival for Patients with Laryngeal Squamous Cell Carcinoma.
    Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
    DNA Cell Biol; 2021 Feb; 40(2):247-264. PubMed ID: 33481663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
    Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
    Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
    Janoray G; Pointreau Y; Garaud P; Chapet S; Alfonsi M; Sire C; Jadaud E; Calais G
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26681800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
    Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.